ECSP961634A - Agonistas, antagonistas de estrogenos - Google Patents

Agonistas, antagonistas de estrogenos

Info

Publication number
ECSP961634A
ECSP961634A ECSP961634A ECSP961634A EC SP961634 A ECSP961634 A EC SP961634A EC SP961634 A ECSP961634 A EC SP961634A EC SP961634 A ECSP961634 A EC SP961634A
Authority
EC
Ecuador
Prior art keywords
agonists
estrogen antagonists
diseases
estrogen
antagonists
Prior art date
Application number
Other languages
English (en)
Inventor
Robert L Rosati
Kimberly O'keefe Cameron
Jardine Paul A Dasilva
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Priority to ECSP961634 priority Critical patent/ECSP961634A/es
Publication of ECSP961634A publication Critical patent/ECSP961634A/es

Links

Abstract

Compuestos de fórmula: Utiles para el tratamiento o prevención de la obesidad, cáncer de mama, osteoporosis, endometriosis, enfermedades cardiovasculares y enfermedades prostáticas.
ECSP961634 1996-01-09 1996-01-09 Agonistas, antagonistas de estrogenos ECSP961634A (es)

Priority Applications (1)

Application Number Priority Date Filing Date Title
ECSP961634 ECSP961634A (es) 1996-01-09 1996-01-09 Agonistas, antagonistas de estrogenos

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ECSP961634 ECSP961634A (es) 1996-01-09 1996-01-09 Agonistas, antagonistas de estrogenos

Publications (1)

Publication Number Publication Date
ECSP961634A true ECSP961634A (es) 1997-06-11

Family

ID=42042368

Family Applications (1)

Application Number Title Priority Date Filing Date
ECSP961634 ECSP961634A (es) 1996-01-09 1996-01-09 Agonistas, antagonistas de estrogenos

Country Status (1)

Country Link
EC (1) ECSP961634A (es)

Similar Documents

Publication Publication Date Title
YU596A (sh) Estrogen agonisti/antagonisti
PT1187632E (pt) Tratamento com anticorpos anti-erbb2
EP0897726A4 (en) ANTI-CURRENT AGENT
DE60006280D1 (de) Beta 2 -adrenergische rezeptor-agonisten
EP2053129A8 (en) Method of diagnosing, monitoring, staging, imaging and treating various cancers
MY122020A (en) Use of gabab receptor agonists as reflux inhibitors
SI1556058T1 (sl) Farmacevtski sestavki, ki obsegajo estetrolne derivate, za uporabo pri zdravljenju raka
DE69942827D1 (de) Verwendung der epothilons zur behandlung der krebs
AR032432A1 (es) Combinaciones oncoliticas para el tratamiento de cancer
AR016981A2 (es) Polipeptidos sinteticos
CU23088A3 (es) Compuestos de tetra-hidropiridina.
IS5035A (is) Aðferðir til varnar gegn brjóstakrabbameini
PL353245A1 (en) Chalcone coumarins
DZ2665A1 (fr) Conjugués utiles pour le traitement du cancer de la prostate.
EA200200943A1 (ru) Гормональная терапия рака молочной железы
EP1382350A4 (en) MEANS AGAINST THE PROPHYLAXIS BEFORE POSTOPERATIVE REPEAT OF PREMOPEOPAUSAL BREAST CANCER
ECSP961634A (es) Agonistas, antagonistas de estrogenos
DE60001851D1 (de) Neue chalchone
HK1050533A1 (en) Substituted pyrroles as antiproliferative agents for the treatment of cancer.
ZA200003235B (en) Combination therapy for the treatment of migraine.
ZA200002338B (en) Combination therapy for the treatment of migraine.
WO2000036144A3 (en) Cancer diagnostic method using p40 subunit of eif3
WO2000057860A3 (en) Peroxovanadium compounds as antineoplastic agents for the treatment of cancer
NZ516209A (en) Indoloazepines as vasopressin receptor antagonists
ZA200002343B (en) Combination therapy for the treatment of migraine.